Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

1. Levis, M.
2. Ravandi, F.
3. Wang, E.S.
4. Baer, M.R.
5. Perl, A.
6. Coutre, S.
7. Erba, H.
8. Stuart, R.K.
9. Baccarani, M.
10. Cripe, L.D.
11. Tallman, M.S.
12. Meloni, G.
13. Godley, L.A.
14. Langston, A.A.
15. Amadori, S.
16. Lewis, I.D.
17. Nagler, A.
18. Stone, R.
19. Yee, K.
20. Advani, A.
21. Douer, D.
22. Wiktor-Jedrzejczak, W.
23. Juliusson, G.
24. Litzow, M.R.
25. Petersdorf, S.
26. Sanz, M.
27. Kantarjian, H.M.
28. Sato, T.
29. Tremmel, L.
30. Bensen-Kennedy, D.M.
31. Small, D.
32. Smith, B.D.
33. Mostrar todos los/as autores/as +